ERCC2 and central nervous system cancer: However, the stratified analysis uncovered either XPD rs13181 TG/GG genotypes by comparison with TT genotypes, or carriers with 2‐3 genotypes when compared to 0‐1 genotypes, escalating glioma risk in the subgroup of astrocytic tumors.